Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Robert M. Winslow"'
Autor:
Robert M. Winslow
Publikováno v:
Surgical technology international.
Blood substitutes are solutions intended to replace transfusion of banked red blood cells. Several variations of products based on either hemoglobin (animal or human) or perfluorocarbon emulsions are in advanced stages of clinical development. The ne
Autor:
Robert M. Winslow
Publikováno v:
Transfusion. 53:424-437
Cell-free hemoglobin (Hb) has been blamed for a spectrum of problems, including vasoconstriction pancreatitis, myocardial infarction, and pulmonary hypertension in hemolytic anemia, malaria, and sickle cell anemia, and from Hb-based oxygen carriers (
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 23:339-347
Objectives Hemospan (Sangart Inc, San Diego, CA) (MP4) is a hemoglobin-based oxygen carrier consisting of human hemoglobin modified with polyethylene glycol. This study evaluated the effects of MP4 on blood volume, hemodynamics, and metabolic stabili
Autor:
Robert M. Winslow
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1784:1382-1386
The most significant hurdle to the development of a safe and effective hemoglobin-based oxygen carrier (“blood substitute”) is generally thought to be its propensity to cause vasoconstriction in the microcirculation and hypertension. Two theories
Autor:
Kim D. Vandegriff, Ashok Malavalli, M A Young, Michele Samaja, Robert M. Winslow, J Lohman, Andrea Bellelli
Publikováno v:
British Journal of Pharmacology. 154:1649-1661
Background and purpose: MP4 (Hemospan) is a Hb-based oxygen therapeutic agent, based on polyethylene-glycol (PEG) conjugation to Hb, undergoing clinical trials as an oxygen carrier. This study describes the functional interaction between MP4 and carb
Autor:
Marcos Intaglietta, Robert M. Winslow
Publikováno v:
Transfusion. 48:411-414
Autor:
B. Fagrell, Robert M. Winslow, P. E. Keipert, Christina Olofsson, R. Przybelski, S. Ponzer, E. B. Nygårds, N. Winslow
Publikováno v:
Transfusion Medicine. 18:28-39
The objective of this study was to further explore the safety of Hemospan (Sangart Inc., San Diego, CA, USA), an oxygen-carrying plasma expander. The aim of this study was to determine if Hemospan is well tolerated in orthopaedic surgery patients wit
Autor:
Calle Nilsson, Fredrik Ekström, Dmitri I. Svergun, Kim D. Vandegriff, Robert M. Winslow, Dale Baker, Ashok Malavalli
Publikováno v:
Biophysical journal 94, 173-181 (2008). doi:10.1529/biophysj.107.114314
Developing protein therapeutics has posed challenges due to short circulating times and toxicities. Recent advances using poly(ethylene) glycol (PEG) conjugation have improved their performance. A PEG-conjugated hemoglobin (Hb), Hemospan, is in clini
Publikováno v:
Transfusion Alternatives in Transfusion Medicine. 9:213-225
SUMMARY Hemoglobin-based oxygen carriers have been under development for several decades, but so far none has completed clinical trials due to safety issues, including fundamental concerns regarding hemoglobin-induced vasoconstriction and oxidative r
Publikováno v:
Journal of Trauma: Injury, Infection & Critical Care. 63:1234-1244
BACKGROUND Maleimide-polyethylene glycol hemoglobin, 4.3 g/dL (MP4), is a hemoglobin-based oxygen carrier consisting of native human hemoglobin modified with maleimide polyethylene glycol. This study evaluated resuscitation with MP4 after uncontrolle